123 related articles for article (PubMed ID: 37425789)
1. XPA tumor variants lead to defects in NER that sensitize cells to cisplatin.
Blee AM; Gallagher KS; Kim HS; Kim M; Troll CR; D'Souza A; Park J; Neufer PD; Schärer OD; Chazin WJ
bioRxiv; 2023 Jul; ():. PubMed ID: 37425789
[TBL] [Abstract][Full Text] [Related]
2. XPA tumor variant leads to defects in NER that sensitize cells to cisplatin.
Blee AM; Gallagher KS; Kim HS; Kim M; Kharat SS; Troll CR; D'Souza A; Park J; Neufer PD; Schärer OD; Chazin WJ
NAR Cancer; 2024 Mar; 6(1):zcae013. PubMed ID: 38500596
[TBL] [Abstract][Full Text] [Related]
3. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
[TBL] [Abstract][Full Text] [Related]
4. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
Gentile F; Tuszynski JA; Barakat KH
J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
[TBL] [Abstract][Full Text] [Related]
5. Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xeroderma pigmentosun group A antisense RNA in human lung adenocarcinoma cells.
Wu X; Fan W; Xu S; Zhou Y
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5874-9. PubMed ID: 14676109
[TBL] [Abstract][Full Text] [Related]
6. Nucleotide excision repair by mutant xeroderma pigmentosum group A (XPA) proteins with deficiency in interaction with RPA.
Saijo M; Takedachi A; Tanaka K
J Biol Chem; 2011 Feb; 286(7):5476-83. PubMed ID: 21148310
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction.
Barakat KH; Jordheim LP; Perez-Pineiro R; Wishart D; Dumontet C; Tuszynski JA
PLoS One; 2012; 7(12):e51329. PubMed ID: 23272099
[TBL] [Abstract][Full Text] [Related]
8. [Enhancement effect of nucleotide excision repair gene xeroderma pigmentosun group a antisense RNA on sensitivity of human lung adenocarcinoma cell line A549 to cisplatin].
Fan W; Zhang HL; Wu XM
Ai Zheng; 2005 Apr; 24(4):403-7. PubMed ID: 15820060
[TBL] [Abstract][Full Text] [Related]
9. Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts.
de Waard H; Sonneveld E; de Wit J; Esveldt-van Lange R; Hoeijmakers JH; Vrieling H; van der Horst GT
DNA Repair (Amst); 2008 Oct; 7(10):1659-69. PubMed ID: 18634906
[TBL] [Abstract][Full Text] [Related]
10. Analysis of DNA binding by human factor xeroderma pigmentosum complementation group A (XPA) provides insight into its interactions with nucleotide excision repair substrates.
Sugitani N; Voehler MW; Roh MS; Topolska-Woś AM; Chazin WJ
J Biol Chem; 2017 Oct; 292(41):16847-16857. PubMed ID: 28860187
[TBL] [Abstract][Full Text] [Related]
11. Elevation of XPA protein level in testis tumor cells without increasing resistance to cisplatin or UV radiation.
Köberle B; Roginskaya V; Zima KS; Masters JR; Wood RD
Mol Carcinog; 2008 Aug; 47(8):580-6. PubMed ID: 18240296
[TBL] [Abstract][Full Text] [Related]
12. Differential DNA damage responses in p53 proficient and deficient cells: cisplatin-induced nuclear import of XPA is independent of ATR checkpoint in p53-deficient lung cancer cells.
Li Z; Musich PR; Zou Y
Int J Biochem Mol Biol; 2011 Apr; 2(2):138-145. PubMed ID: 21643554
[TBL] [Abstract][Full Text] [Related]
13.
Li Q; Damish AW; Frazier Z; Liu D; Reznichenko E; Kamburov A; Bell A; Zhao H; Jordan EJ; Gao SP; Ma J; Abbosh PH; Bellmunt J; Plimack ER; Lazaro JB; Solit DB; Bajorin D; Rosenberg JE; D'Andrea AD; Riaz N; Van Allen EM; Iyer G; Mouw KW
Clin Cancer Res; 2019 Feb; 25(3):977-988. PubMed ID: 29980530
[TBL] [Abstract][Full Text] [Related]
14. SIRT1 regulates UV-induced DNA repair through deacetylating XPA.
Fan W; Luo J
Mol Cell; 2010 Jul; 39(2):247-58. PubMed ID: 20670893
[TBL] [Abstract][Full Text] [Related]
15. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.
Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD
J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136
[TBL] [Abstract][Full Text] [Related]
16. Metal binding mediated conformational change of XPA protein:a potential cytotoxic mechanism of nickel in the nucleotide excision repair.
Hu J; Hu Z; Zhang Y; Gou X; Mu Y; Wang L; Xie XQ
J Mol Model; 2016 Jul; 22(7):156. PubMed ID: 27307058
[TBL] [Abstract][Full Text] [Related]
17. Xeroderma pigmentosum group A protein loads as a separate factor onto DNA lesions.
Rademakers S; Volker M; Hoogstraten D; Nigg AL; Moné MJ; Van Zeeland AA; Hoeijmakers JH; Houtsmuller AB; Vermeulen W
Mol Cell Biol; 2003 Aug; 23(16):5755-67. PubMed ID: 12897146
[TBL] [Abstract][Full Text] [Related]
18. XPA protein as a limiting factor for nucleotide excision repair and UV sensitivity in human cells.
Köberle B; Roginskaya V; Wood RD
DNA Repair (Amst); 2006 May; 5(5):641-8. PubMed ID: 16413230
[TBL] [Abstract][Full Text] [Related]
19. p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.
Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; Gielis S; Vermeulen JP; Wester PW; Vos JG; de Vries A; van Steeg H
Cancer Res; 2004 Aug; 64(15):5118-26. PubMed ID: 15289314
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the human xeroderma pigmentosum group A gene and their impact on cell survival and nucleotide excision repair.
Mellon I; Hock T; Reid R; Porter PC; States JC
DNA Repair (Amst); 2002 Jul; 1(7):531-46. PubMed ID: 12509227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
